Physician profile
Mitchell C Tarka
NPI 1235661489
$7,054.16
in general payments reported to CMS, 2019-2025
9 companies · $18.01 in 2025
The $18.01 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,000 · 2023: $1,671 · 2024: $365 · 2025: $18.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Travel and Lodging: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.24 |
| Travel and Lodging | $728.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,877.92 | 2022-2023 | |
| Elite Orthopedics, LLC | $293.89 | 2023-2024 | |
| Paragon 28, INC. | $283.58 | 2023 | Silverback, Gorilla, Grappler |
| Exactech, INC. | $233.71 | 2023 | |
| Stryker Corporation | $145.43 | 2023-2025 | Allofiber, Inbone |
| Linvatec Corporation | $135.72 | 2024 | Biobrace 23mm |
| Bioventus LLC | $43.32 | 2024 | Durolane |
| Abbott Laboratories | $23.46 | 2023 | Proclaim |
| Zimmer Biomet Holdings, INC. | $17.13 | 2024 | Tapestry, Stratum Foot Plating System, Ventix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Tarka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.